Tirzepatide (Zepbound®) for Weight Loss — Online in Texas
Zepbound® and Mounjaro® — a dual GIP/GLP-1 therapy prescribed by Dr. Dean or Dr. Kline after a real physician consultation. Not an algorithm. Not a chatbot. Your doctor.
Quick Answer
What is tirzepatide and how do I get it in Texas?
Tirzepatide is a once-weekly injectable dual GIP/GLP-1 receptor agonist (the active ingredient in Zepbound® and Mounjaro®) FDA-approved for chronic weight management and type 2 diabetes. Trinity Family Medicine prescribes tirzepatide via telehealth to eligible adults located in Texas after a video visit with a board-certified physician, with medication shipped from a licensed pharmacy. Bundled plans start at $200/month including medication and visits.
- FDA-approved for chronic weight management at BMI ≥30, or ≥27 with a weight-related condition
- Average weight loss of ~20.9% at the highest dose over 72 weeks in the SURMOUNT-1 trial (NEJM, 2022)
- $200/month bundle (medication + physician visits) or $74.99 visit-only
- Carries an FDA Boxed Warning — not for patients with personal/family history of MTC or MEN 2
- Gradual dose titration starting at 2.5 mg weekly to minimize GI side effects
- Same physician manages titration and ongoing monitoring
What Is Tirzepatide?
A leading dual-action GLP-1 medication — backed by the landmark SURMOUNT clinical trials.
Tirzepatide is a first-in-class dual GIP/GLP-1 receptor agonist — meaning it targets two gut hormone pathways instead of one. It is the active ingredient in Zepbound® (FDA-approved for chronic weight management) and Mounjaro® (FDA-approved for Type 2 diabetes).
In the SURMOUNT clinical trials, patients taking tirzepatide lost an average of 20–25% of their body weight over 72 weeks. For a 250-pound patient, that's roughly 50–62 pounds. In published head-to-head data, tirzepatide produced greater average weight loss than semaglutide; individual results vary based on adherence, lifestyle, and metabolism.
The dual-action mechanism is what sets tirzepatide apart: by activating both GIP and GLP-1 receptors, it enhances insulin sensitivity, reduces appetite more effectively, and promotes greater fat loss than single-receptor medications. Like semaglutide, it's a once-weekly injection.
Appetite Suppression
Signals brain via GLP-1 pathway
GIP Activation
Second hormone pathway amplifies results
Slows Digestion
Extended satiety after meals
Strong Weight Loss Outcomes
20–25% avg body weight reduction in trials
Why Trinity Is Different
Real physicians. Real relationships. A practice built for patients, not shareholders.
Your Doctor, Every Time
No rotating providers. No chatbot prescriptions. Dr. Dean and Dr. Kline personally manage every patient's care — building a real relationship so your treatment evolves with you.
Physician-Owned, Not Venture Capitalist Backed
Trinity isn't a tech startup optimizing for investor returns. It's a medical practice built by doctors who believe weight loss deserves real medicine, not algorithms.
DPC Model = More Time With You
Direct Primary Care means no insurance red tape, longer visits, and a doctor who actually knows your chart. You're a patient here — not a number.
Tirzepatide Dosing Schedule
A gradual titration schedule designed to maximize results while minimizing side effects.
Weeks 1–4
2.5 mgStarting dose — body adjusts to medication
Weeks 5–8
5 mgFirst increase — appetite effects strengthen
Weeks 9–12
7.5 mgContinued titration based on response
Weeks 13–16
10 mgMany patients achieve target here
Weeks 17–20
12.5 mgEscalation if clinically appropriate
Week 21+
15 mgMaximum dose for optimal weight loss
Note from your physicians: This schedule follows FDA labeling guidelines. Dr. Dean and Dr. Kline personalize your dosing based on your response, tolerability, and weight loss progress. Many patients achieve excellent results at 10 mg without needing to reach the maximum dose. Your physician adjusts the plan to what works best for you.
Tirzepatide Side Effects
Transparent information so you can make an informed decision.
Important Safety Information: GLP-1 medications may cause serious side effects including risk of thyroid C-cell tumors. Do not use tirzepatide if you or your family have a history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Rare but serious side effects include pancreatitis, gallbladder problems, hypoglycemia (especially in patients with diabetes on other medications), and severe allergic reactions. Dr. Dean and Dr. Kline monitor you closely throughout treatment.
FDA & Compounded Tirzepatide — What You Should Know (2026)
The FDA officially resolved the GLP-1 shortage in February 2025. Since then, large-scale compounding of tirzepatide has been significantly restricted. At Trinity, we prioritize FDA-approved brand-name Zepbound® / Mounjaro® when clinically appropriate and accessible. Compounded alternatives are only used in specific clinical circumstances (such as documented allergies to brand fillers or inability to tolerate a commercial dose), and only through licensed, accredited (PCAB / NABP) compounding pharmacies that can produce a Certificate of Analysis on request.
Be cautious of medspas or websites offering "cheap" tirzepatide without a licensed prescribing physician, lab oversight, or pharmacy verification — these are the patient-safety red flags the FDA and Texas State Board of Pharmacy have repeatedly warned about.
Transparent Pricing
No hidden fees. No surprise bills.
Monthly Subscription
Save money with an all-inclusive plan — medication and physician visits bundled together.
- Medication included & shipped to your door
- Visit fees waived — $0 for every consultation
- Same physician, same personalized care
- Cancel anytime — no long-term contracts
Initial Consultation
Your first visit with Dr. Dean or Dr. Kline
- Comprehensive video visit
- Full health assessment & history review
- Personalized treatment plan
- Medication selection & dosing
- Nutrition guidance
3-Month Follow-Up
Ongoing care every 3 months
- Progress check-in visit
- Dose adjustment as needed
- Side effect management
- Updated treatment plan
- Direct physician access between visits
Medication Cost
Separate from visit fees
- Brand-name: market pricing
- Compounded: significantly lower cost
- Ships directly to your door
- Licensed, accredited pharmacies
- Your physician helps find the best option
Medicare $50 GLP-1 Program Available
Starting July 2026, eligible Medicare Part D enrollees can get Wegovy, Zepbound, or Foundayo for just $50 per month through the Medicare GLP-1 Bridge program. Qualification is based on BMI and health history — BMI 35+ qualifies automatically; BMI 30+ with heart failure, uncontrolled high blood pressure, or chronic kidney disease; or BMI 27+ with prediabetes or history of heart attack, stroke, or peripheral artery disease. If you already receive a GLP-1 through Medicare for diabetes, sleep apnea, or fatty liver disease, you do not qualify.
Learn more about qualifications and how to applyAm I Eligible?
Answer a few quick questions to see if GLP-1 treatment may be right for you.
Tirzepatide FAQ
Physician-written answers about tirzepatide treatment at Trinity.
Meet Your Physicians
Two board-certified physicians. One patient-centered practice.
Casey Dean, DO
Board-Certified Family Medicine Physician
Dr. Dean is a board-certified family medicine physician and co-founder of Trinity Family Medicine. With specialized expertise in metabolic restoration, he takes a patient-first approach to weight management — treating obesity as the complex metabolic condition it is, not a willpower problem.
- Board-Certified, Family Medicine
- TMB License #T3065
- NPI: 1134744824
Kathryn Kline, MD
Board-Certified Family Medicine Physician
Dr. Kline is a board-certified family medicine physician and co-founder of Trinity Family Medicine. Her background in metabolic strategy and women's health brings a thoughtful, holistic perspective to weight loss care — combining medication with nutrition guidance and ongoing physician support.
- Board-Certified, Family Medicine
- TMB License #T3117
- NPI: 1821613514
"Weight loss is a medical journey — and every patient deserves a physician who walks it with them, not just a subscription that ships a box."
Considering Other Options?
Your physician will help you choose the best medication for your goals. Here's how the other option compares.
Semaglutide
Wegovy® / Ozempic®
The most studied GLP-1 medication for weight loss with proven results averaging 15% body weight reduction. A trusted first-line option for many patients.
Ready to Start Your Weight Loss Journey?
Book a consultation with Dr. Dean or Dr. Kline — most patients get started within 24 hours.
GLP-1 medications may cause serious side effects including risk of thyroid tumors. Do not use if you or your family have a history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Compounded medications are not FDA-approved for safety, efficacy, or quality. Individual results may vary. Trinity Family Medicine provides telehealth services to patients who are physically located in Texas* at the time of service.